DF-461

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameDF-461
Drug Alias NameDF-461
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene synthase inhibitors
TargetsSqualene synthase
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A